Side Effect Management.
Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. Journal of Surgical Oncology, 103 4 , 330-336. February 2015. This literature review highlights the continuing lack of understanding regarding the motivations of patients newly diagnosed with breast cancer and the role of providers who interact with them during the initial crucial weeks of decision making already recognized by leading medical professionals Kahn, 2011.
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
Also, of concern to women in surgical decision making are the adverse effects of radiation or the inconvenience of adding radiation to an already-complicated treatment regimen following BCS Sepucha et al.
By continuing to use our site, you accept the use of these cookies. Survival outcomes after contralateral prophylactic mastectomy: The rate of patients undergoing contralateral prophylactic mastectomy has risen significantly in the United States.
Password Keep me logged in. Rates of contralateral prophylactic mastectomy CPM are on the rise despite lack of benefit regarding survival or prevention of metastatic recurrence; moreover, 10-year risk for developing a new contralateral breast cancer is very low in the absence of genetic predisposition.
Contralateral prophylactic mastectomy for unilateral breast cancer: Involving patients in the decision-making process regarding breast cancer treatment: In a 2010 Cochrane review Lostumbo et al.
Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
In alignment with the American Board of Internal Medicine's Choosing Wisely initiative designed to reduce overutilization and cost in medical practice , the American Society of Breast Surgeons discourages routine use of double mastectomy in patients with unilateral breast cancer see http: Article Content Breast cancer is the most common malignancy in women and second only to lung cancer as the cause of cancer-related deaths among women in North America and Western Europe.
And Tomorrow? Download Now. While level I evidence would be ideal to confirm these retrospective population based observations, such evidence is not likely to ever be had. Journal of the National Cancer Institute, 85 13 , 1074-1080. October 2016.
Studies have shown that the addition of a contralateral prophylactic mastectomy carries a 1. Feb 27.